ACG Appoints New CEO

ACG, a supplier of pharmaceutical and nutraceutical solutions, announced on Dec. 7, 2020 that it has named Dr. Marcus Michel as its new CEO. Michel will take over the role from Richard Stedman, who has served as CEO for the past three years, as he transitions to a special advisor role for the company.

Michel has more than 25 years of experience in mechanical, process, and plant engineering for the pharmaceutical, chemical, and allied industries and previously held the position of executive vice president for the GEA Pharma Solutions Business at the GEA Group. He has also held leadership roles at Sued-Chemie, Thyssen Krupp Uhde, and Haldor Topsoe.

“We are very excited to welcome Dr. Marcus Michel to the ACG family,” said Karan Singh, managing director, ACG, in the press release.“He is the right person to lead ACG Engineering into the future, given his command of our business and proven ability to drive results. His track record, depth of international experience, and familiarity with the industry will be highly beneficial in ACG’s growth. I also wish to thank, Richard Stedman, who has helped institutionalize many standard systems and processes across the ACG Engineering group.”